A first-of-its-kind implant has just been granted approval from the US Food and Drug Administration (FDA) for the treatment ...

The device stimulates the vagus nerve, signaling the body to tamp down the inflammation that contributes to the disease.

SetPoint Medical's vagus nerve stimulator has received FDA approval for treating moderate-to-severe rheumatoid arthritis (RA) ...

The agency’s decision was based on the outcomes of the double-blind, randomised, sham-controlled RESET-RA study.

SetPoint Medical, a company dedicated to developing therapies for people living with chronic autoimmune diseases, today ...

SetPoint Medical announced today that the FDA approved its SetPoint neuroimmune modulation system for treating rheumatoid ...

The US Food and Drug Administration has approved a pill-sized device for treating rheumatoid arthritis, marking the first ...

The Food and Drug Administration has approved a vagus nerve bioimplant to treat rheumatoid arthritis (RA). The scientific ...

The SetPoint System consists of a neurostimulation device that is surgically placed under general anesthesia on the vagus nerve.

Treatment with the SetPoint System, a neuroimmune modulation device, was associated with significant clinical benefit in adults with moderate to severe rheumatoid arthritis (RA), according to ...

The FDA has approved a medical device that stimulates the vagus nerve for the treatment of moderate-to-severe rheumatoid ...

The FDA has approved the SetPoint System, a vagus nerve stimulator from SetPoint Medical, for the treatment of rheumatoid ...